A promising future for gemcitabine-oxaliplatin in cisplatin-unfit advanced urothelial carcinoma

Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUCПодробнее

Nivolumab + Gemcitabine-Cisplatin vs. Gemcitabine-Cisplatin in Metastatic Urothelial Cancer | CRSFПодробнее

CheckMate 901: nivolumab with gemcitabine-cisplatin in urothelial carcinomaПодробнее

Receiving Carboplatin and Gemcitabine for cancerПодробнее

Gemcitabine, Cisplatin, and Nab-paclitaxel in Advanced Biliary Tract CancerПодробнее

Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of MIBC patientsПодробнее

Enzalutamide, Gemcitabine, and Cisplatin for Metastatic Bladder CancerПодробнее

COACH trial update: GemOx vs. GCb in cisplatin-unfit advanced urothelial carcinomaПодробнее

Where does oxaliplatin fit in the treatment paradigm for advanced metastatic pancreatic cancer?Подробнее

Phase-2 trial of gemcitabine, cisplatin + nivolumab with selective bladder sparing in MIBC patientsПодробнее

CALGB 90601: Comparing gemcitabine and cisplatin with bevacizumab to placebo for metastatic urot...Подробнее

BATTLING BLADDER CANCER WITH GEMCITABINEПодробнее

Cisplatin-Ineligible Treatment Options for Advanced Bladder Cancer - Bladder Cancer Video LibraryПодробнее

Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancerПодробнее

Addressing the impact of neoadjuvant treatment for MIBC in the NIAGARA trialПодробнее

HRQoL in KEYNOTE-966: pembrolizumab with gemcitabine and cisplatin for advanced biliary tract cancerПодробнее

SWOG 1815: gemcitabine, cisplatin, and nab-paclitaxel in biliary tract cancerПодробнее

Gemcitabine, cisplatin, and nab-paclitaxel in advanced biliary tract cancersПодробнее

Phase II study of neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with MIBCПодробнее